Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 14, 2009; 15(18): 2177-2183
Published online May 14, 2009. doi: 10.3748/wjg.15.2177
Published online May 14, 2009. doi: 10.3748/wjg.15.2177
Well-differentiated tumor-carcinoid |
Benign behavior: confined to mucosa-submucosa, non-angioinvasive, ≤ 1 cm in size, non-functioning |
ECL cell tumor of corpus-fundus associated with hypergastrinemia and chronic atrophic gastritits (CAG) or MEN1 syndrome |
Serotonin-producing tumor |
Gastrin-producing tumor |
Uncertain behavior: confined to mucosa-submucosa, > 1 cm in size, or angioinvasive |
ECL cell tumor with CAG or MEN1 syndrome or sporadic |
Serotonin-producing tumor |
Gastrin-producing tumor |
Well-differentiated endocrine carcinoma-malignant carcinoid |
Low-grade malignant, deeply invasive (muscularis propria or beyond), or with metastasis |
Nonfunctioning |
ECL cell carcinoid, usually sporadic, rarely in CAG or MEN1 syndrome |
Serotonin-producing tumor |
Gastrin-producing tumor |
Functioning |
ECL cell carcinoid with atypical carcinoid syndrome |
Serotonin-producing carcinoid with syndrome |
Gastrin-producing carcinoma-malignant gastrinoma |
ACTH-producing carcinoma with Cushing syndrome |
Poorly differentiate endocrine carcinoma-small cell carcinoma, high grade malignant, usually non-functioning, occasionally with Cushing syndrome |
- Citation: Massironi S, Sciola V, Spampatti MP, Peracchi M, Conte D. Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol 2009; 15(18): 2177-2183
- URL: https://www.wjgnet.com/1007-9327/full/v15/i18/2177.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2177